[多发性硬化症的治疗]
Nandi Meijs1,2, Brigit A De Jong3, Bob W Van Oosten3
1Zuyderland Medisch Centrum, afd. Neurologie, Sittard/Heerlen.
Nederlands tijdschrift voor geneeskunde
|May 15, 2024
概括
多发性硬化症 (MS) 的管理是复杂的,特别是与共发生的自身免疫性疾病. 本案例研究强调了当患者同时患有克罗恩病等疾病时,选择有效的多发性硬化症治疗的挑战和机会.
科学领域:
- 神经免疫学 神经免疫学
- 自免疫性疾病 自免疫性疾病
- 临床神经学 临床神经学
背景情况:
- 多发性硬化症 (MS) 是一种由自身免疫驱动的慢性中枢神经系统炎症性疾病.
- 多发性硬化症的治疗选择已经显著扩大.
- 在患有其他自身免疫性疾病的患者中治疗多发性硬化症具有独特的临床考虑.
研究的目的:
- 介绍多发性硬化症的两个不同的临床病例.
- 为了说明MS治疗的复杂性,在同时发生的自身免疫性疾病的背景下.
- 在存在多种自身免疫性疾病时探索治疗策略.
主要方法:
- 两名患有多发性硬化症的患者的病例报告介绍.
- 审查治疗反应和疾病的过程.
- 同时存在的自身免疫性疾病的治疗影响的分析.
主要成果:
- 患者A表现出复发性缓解性多发性硬化症疗程,并通过二线治疗有效管理.
- 患者B在启动克罗恩病TNF-alpha阻断后经历了新的MS复发.
- 不同的自身免疫性疾病之间的相互作用会影响治疗决策.
结论:
- 诸如多发性硬化和克罗恩病之类的自身免疫性疾病的同时出现使治疗选择复杂化.
- 仔细考虑治疗相互作用对于优化患者的治疗结果至关重要.
- 同时存在的自身免疫性疾病为量身定制和潜在的协同作用的治疗策略提供了机会.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Alzheimer's Disease: Treatment
181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
Parkinson's Disease: Treatment
263
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
263
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
158
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
158
Autoimmune Disorders
417
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
417
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K


